Emerging biopharmaceuticals from marine actinobacteria.

Abstract

Actinobacteria are quotidian microorganisms in the marine world, playing a crucial ecological role in the recycling of refractory biomaterials and producing novel secondary metabolites with pharmaceutical applications. Actinobacteria have been isolated from the huge area of marine organisms including sponges, tunicates, corals, mollusks, crabs, mangroves and seaweeds. Natural products investigation of the marine actinobacteria revealed that they can synthesize numerous natural products including alkaloids, polyketides, peptides, isoprenoids, phenazines, sterols, and others. These natural products have a potential to provide future drugs against crucial diseases like cancer, HIV, microbial and protozoal infections and severe inflammations. Therefore, marine actinobacteria portray as a pivotal resource for marine drugs. It is an upcoming field of research to probe a novel and pharmaceutically important secondary metabolites from marine actinobacteria. In this review, we attempt to summarize the present knowledge on the diversity, chemistry and mechanism of action of marine actinobacteria-derived secondary metabolites from 2007 to 2016.

DOI: 10.1016/j.etap.2016.11.015

Cite this paper

@article{Hassan2017EmergingBF, title={Emerging biopharmaceuticals from marine actinobacteria.}, author={Syed Shams Ul Hassan and Komal Anjum and Syed Qamar Abbas and Najeeb Akhter and Bibi Ibtesam Shagufta and Sayed Asmat Ali Shah and Umber Tasneem}, journal={Environmental toxicology and pharmacology}, year={2017}, volume={49}, pages={34-47} }